tiprankstipranks
Novartis reports Q2 core EPS $1.97, consensus $1.89
PremiumThe FlyNovartis reports Q2 core EPS $1.97, consensus $1.89
4d ago
NVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
Options Volatility and Implied Earnings Moves This Week, July 15 – July 19, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, July 15 – July 19, 2024
7d ago
Lexicon appoints Mike Exton as CEO, Jeff Wade as COO
PremiumThe FlyLexicon appoints Mike Exton as CEO, Jeff Wade as COO
14d ago
Novartis price target raised to $122.50 from $121 at Jefferies
PremiumThe Fly
Novartis price target raised to $122.50 from $121 at Jefferies
20d ago
MorphoSys and Novartis sign delisting agreement
PremiumThe Fly
MorphoSys and Novartis sign delisting agreement
1M ago
Novartis presents results from interim analysis of Phase III ALIGN study
PremiumThe FlyNovartis presents results from interim analysis of Phase III ALIGN study
2M ago
Novartis presents latest Phase III Fabhalta data in C3 glomerulopathy
PremiumThe Fly
Novartis presents latest Phase III Fabhalta data in C3 glomerulopathy
2M ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies healthcare analyst holds an analyst/industry conference call
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100